财务摘要（报告期）（Quince Therapeutics Inc）
| 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|
| 每股指标： | ||||||||
| 每股收益EPS基本(元) | -0.84 | -0.63 | -0.48 | -0.34 | -1.54 | -1.41 | -1.22 | -0.72 |
| 每股净资产(元) | 1.98 | 2.29 | 2.39 | 2.49 | 2.78 | 2.89 | 3.10 | 3.53 |
| 每股经营现金净流量(元) | -0.43 | -0.34 | -0.20 | -0.10 | -1.22 | -1.06 | -0.88 | -0.53 |
| 每股现金流量净额(元) | -0.55 | -0.63 | -0.60 | 0.06 | -0.70 | -1.05 | -0.63 | -0.07 |
| 盈利能力： | ||||||||
| 净资产收益率平均(%) | -33.81 | -24.48 | -18.28 | -12.85 | -47.14 | -41.35 | -33.20 | -19.24 |
| 总资产净利率(%) | -23.09 | -23.76 | -17.79 | -12.43 | -43.57 | -37.96 | -30.43 | -17.36 |
| 投入资本回报率ROIC(%) | -30.40 | -36.55 | -27.31 | -23.13 | -84.11 | -65.21 | -56.84 | -38.62 |
| 收益质量： | ||||||||
| 营业利润／利润总额(%) | 109.62 | 108.62 | 106.63 | 103.63 | 100.14 | 98.46 | 98.93 | 101.03 |
| 资本结构： | ||||||||
| 资产负债率(%) | 49.32 | 2.64 | 2.20 | 3.34 | 3.19 | 4.78 | 5.37 | 8.40 |
| 权益乘数 | 1.97 | 1.03 | 1.02 | 1.03 | 1.03 | 1.05 | 1.06 | 1.09 |
| 产权比率 | 0.97 | 0.03 | 0.02 | 0.03 | 0.03 | 0.05 | 0.06 | 0.09 |
| 流动资产／总资产(%) | 46.12 | 99.75 | 99.68 | 99.11 | 90.22 | 89.52 | 84.31 | 82.97 |
| 非流动资产／总资产(%) | 53.88 | 0.25 | 0.32 | 0.89 | 9.78 | 10.48 | 15.69 | 17.03 |
| 流动负债／负债合计(%) | 11.56 | 100.00 | 100.00 | 100.00 | 92.52 | 94.26 | 93.98 | 99.59 |
| 非流动负债／负债合计(%) | 88.44 | - | - | - | 7.48 | 5.74 | 6.02 | 0.41 |
| 归属母公司股东的权益／投入资本(%) | 57.82 | 130.40 | 131.27 | 193.55 | 169.55 | 134.07 | 157.23 | 219.04 |
| 偿债能力： | ||||||||
| 流动比率 | 8.09 | 37.80 | 45.36 | 29.69 | 30.55 | 19.87 | 16.70 | 9.92 |
| 速动比率 | 8.09 | 37.80 | 45.36 | 29.69 | 30.55 | 19.87 | 16.70 | 9.92 |
| 货币资金／流动负债(%) | 216.80 | 960.14 | 1,160.35 | 1,499.65 | 1,452.56 | 643.26 | 788.71 | 695.82 |
| 营业利润／流动负债(%) | -361.68 | -1,096.27 | -949.80 | -415.92 | -1,694.85 | -924.08 | -639.93 | -225.16 |
| 经营活动产生的现金流量净额／流动负债(%) | -191.10 | -542.12 | -378.89 | -114.57 | -1,434.93 | -772.56 | -529.51 | -165.72 |
| 归属母公司股东的权益／负债合计(%) | 102.74 | 3,689.88 | 4,451.02 | 2,895.76 | 3,032.65 | 1,992.58 | 1,761.68 | 1,091.08 |
| 经营活动产生的现金流量净额／负债合计(%) | -22.09 | -542.12 | -378.89 | -114.57 | -1,327.65 | -728.23 | -497.65 | -165.04 |
| 营业利润／负债合计(%) | -41.80 | -1,096.27 | -949.80 | -415.92 | -1,568.13 | -871.06 | -601.42 | -224.24 |
| 成长能力： | ||||||||
| 总资产同比增长率(%) | 61.58 | -22.22 | -24.63 | -19.64 | -22.01 | -25.53 | -26.97 | -33.46 |
| 每股净资产同比增长率(%) | -28.87 | -20.94 | -22.85 | -29.53 | -29.40 | -34.86 | -35.29 | -33.31 |
| 总负债同比增长率(%) | 2,396.71 | -57.05 | -69.17 | -68.05 | -77.35 | -64.47 | -67.21 | -45.95 |
| 基本每股收益同比增长率(%) | 45.45 | 55.32 | 60.66 | 52.78 | 49.17 | 37.33 | 19.74 | 7.69 |
| 归属母公司股东的权益同比增长率(%) | -15.42 | -20.47 | -22.10 | -15.21 | -15.17 | -21.20 | -21.50 | -32.02 |
| 营业利润同比增长率(%) | 33.44 | 45.95 | 51.31 | 40.74 | 42.41 | 31.57 | 15.57 | 6.22 |
| 股东权益合计同比增长率(%) | -15.42 | -20.47 | -22.10 | -15.21 | -15.17 | -21.20 | -21.50 | -32.02 |
| 营运能力： | ||||||||
| 衍生指标： | ||||||||
| 现金及现金等价物净增加额TTM(元) | -23,827,000.00 | -10,177,000.00 | -24,278,000.00 | -20,850,000.00 | -25,145,000.00 | -30,398,000.00 | -27,121,000.00 | -17,751,000.00 |
| 利润总额TTM(元) | -31,582,000.00 | -28,273,000.00 | -30,843,000.00 | -42,805,000.00 | -51,944,000.00 | -69,809,000.00 | -83,594,000.00 | -88,500,000.00 |
| 投入资本(元) | 147,148,000.00 | 63,754,000.00 | 66,186,000.00 | 46,604,000.00 | 59,331,000.00 | 77,968,000.00 | 70,935,000.00 | 48,566,000.00 |
| 经营活动产生的现金流量净额TTM(元) | -18,292,000.00 | -18,049,000.00 | -19,928,000.00 | -31,516,000.00 | -44,038,000.00 | -52,621,000.00 | -63,266,000.00 | -65,413,000.00 |
| 归属母公司净利润TTM(元) | -31,385,000.00 | -28,025,000.00 | -30,595,000.00 | -42,273,000.00 | -51,660,000.00 | -69,525,000.00 | -83,310,000.00 | -88,500,000.00 |
| 所得税TTM(元) | -197,000.00 | -248,000.00 | -248,000.00 | -284,000.00 | -284,000.00 | - | - | - |